Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84820 44022 04623 346
Operating income (EBITDA)11 21612 6164 9745 2125 5126 172
Operating profit (EBIT)9 0109 8334 0463 7524 1554 659
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 6413 1113 518
EPS ( $)3,013,721,621,481,912,27
Dividend per Share ( $)1,881,670,640,880,981,10
Yield4,10%3,64%1,40%1,92%2,15%2,39%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 6743 0863 9272 1341 627
Finance------
Operating income (EBITDA)11 21612 6164 9745 2125 5126 172
Leverage
(Debt/EBITDA)
0,77x0,77x0,62x0,75x0,39x0,26x
Capital Expenditure1 4921 7951 1459891 0821 217
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,6 $18,7 $19,7 $
Cash Flow per Share5,72 $5,85 $2,11 $2,76 $3,20 $3,42 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 69 040 M$ -
Entreprise Value (EV) 72 967 M$ 71 175 M$
Valuation 2014e 2015e
PER (Price / EPS) 31,0x 24,0x
Capitalization / Revenue 3,38x 3,13x
EV / Revenue 3,57x 3,23x
EV / EBITDA 14,0x 12,9x
Yield (DPS / Price) 1,92% 2,15%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,4% 18,8%
operating Leverage (Delta EBIT / Delta Sales) -1,13x 1,37x
Net Margin (Net Profit / Revenue) 12,9% 14,1%
ROA (Net Profit / Asset) 7,53% 7,33%
ROE (Net Profit / Equities) 13,4% 12,9%
Rate of Dividend 59,6% 51,5%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   4,84% 4,91%
Cash Flow / Sales (Taux d'autofinancement) 20,3% 21,8%
Capital Intensity (Assets / Sales) 1,71x 1,93x
Financial Leverage (Net Debt / EBITDA) 0,75x 0,39x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF